David Richards, DO
Cardiovascular Disease · Columbus, OHNPI 1285631366
Payments from drug & device makers
What this record shows
This record is dominated by consulting fees: $42,250 of the $55,137 with a category attached, or 76.6%. Abbott accounts for 95.4% of it on its own, with 7 other manufacturers making up the rest. Reporting peaked in 2021 at $15,813 and has fallen 96.2% since, to $601 in 2025. Among cardiovascular disease clinicians in OH with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 81 payments — averaging $680.70 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Abbott$53K
- Medtronic$2K
- Edwards Lifesciences$184
- Boston Scientific$132
- Jenavalve Technology, Inc.$112
- Actelion Pharmaceuticals US, Inc.$111
- plus $160 from 2 others
What the payments were for
- Consulting fees$42,25077%
- Speaking & faculty fees$2,0004%
- Travel & lodging$8,26615%
- Food & beverage$2,6215%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Abbott | 55 | $52,594 |
| Medtronic(2 entities) | 18 | $1,844 |
| Edwards Lifesciences | 3 | $184 |
| Boston Scientific | 1 | $132 |
| Jenavalve Technology, Inc. | 1 | $112 |
| Actelion Pharmaceuticals US, Inc. | 1 | $111 |
| Heartflow, Inc. | 1 | $101 |
| Philips North America LLC | 1 | $60 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- MitraClip$25,178
- MitraClip System$15,177
- Mitra Clip system$10,546
- CoreValve Evolut$673
- COREVALVE EVOLUT R$248
- WATCHMAN FLX$132
- JenaValve Pericardial TAVR System$112
- UPTRAVI$111
- OPSUMIT$111
- FFRct$101
How this compares
$55,137 in reported general payments places this provider in the 90th percentile of 827 cardiovascular disease providers in Ohio.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EliquisApixaban | 140 | $182,590 |
| EntrestoSacubitril/Valsartan | 74 | $95,110 |
| XareltoRivaroxaban | 45 | $61,597 |
| JardianceEmpagliflozin | 24 | $24,282 |
| Repatha SureclickEvolocumab | 11 | $6,605 |
| Ezetimibe | 140 | $3,967 |
| Eplerenone | 31 | $3,326 |
| Metoprolol Succinate | 199 | $3,021 |
| Atorvastatin Calcium | 230 | $2,556 |
| Candesartan Cilexetil | 19 | $2,258 |
| Colchicine | 38 | $2,238 |
| Flecainide Acetate | 48 | $1,780 |
| Carvedilol | 162 | $1,561 |
| Losartan Potassium | 141 | $1,531 |
| Rosuvastatin Calcium | 111 | $1,283 |
Paid to pharmacies, not to this prescriber.
Other cardiovascular disease in Columbus
- Jayanta MukherjeeColumbus$227K
- Steven DeanColumbus$153K
- Manmohan KatapadiColumbus$124K
- Akira WadaColumbus$49K
- Paul HarnishColumbus$49K
- Guilherme AttizzaniCleveland$1.3M
- Gregory LamCircleville$428K
- Emil HayekHudson$379K
- Abraham LincoffCleveland$369K
- Oussama WazniCleveland$367K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.